Wound healing and local wound treatment in diabetic foot syndrome;Wundheilung und lokale wundbehandlung bei diabetischem fusssyndrom

Internist

Volumn 40, Issue 10, 1999, Pages 1009-1017

  Reike, H ^a  

^a KLINIKUM DORTMUND   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ANTIINFECTIVE AGENT; CHLORHEXIDINE GLUCONATE; HYDROGEN PEROXIDE; OCTENIDINE; POVIDONE IODINE;

ANGIOGENESIS; CELL PROLIFERATION; DEBRIDEMENT; DIABETIC FOOT; GRANULOCYTE FUNCTION; HEMOSTASIS; LIMB SALVAGE; MACROPHAGE FUNCTION; REVIEW; SKIN GRAFT; TOPICAL DRUG ADMINISTRATION; WOUND CARE; WOUND CONTRACTION; WOUND DRESSING; WOUND HEALING;

CLINICAL TRIALS; COMBINED MODALITY THERAPY; DEBRIDEMENT; DIABETIC FOOT; GRANULATION TISSUE; HUMANS; INTERNAL MEDICINE; PATIENT CARE TEAM; SKIN TRANSPLANTATION; WOUND HEALING;

EID: 0032864984     PISSN: 00209554     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001080050431     Document Type: Review

References (49)

1. Apelqvist J, Ragnarson-tennvall G, Persson U, Larsson J (1994) Diabetic foot ulcers in a multidisciplinary setting. An economic analysis of primary healing and healing with amputation. J Int Med 235:463-471
2. Argenta LC, Morykwas MJ (1997) Vacuum-assisted closure: a new method for wound control and treatment: clinical experience. Ann Plast Surg 38:563-76 (discussion 577)
3. Arnold F, Cherry G, Cox D, Hutchinson G, Weston-Davies W (1996) Wound pharmacology: a report from the wound pharmacology forum. Wound Rep Reg 4:121-126
4. Bale S, Banks V, Haglestein S, Harding K-G (1998) A comparison of two amorphous hydrogels in the debridement of pressure sores. J Wound Care 7:65-68
5. Blackman JD, Senseng D, Quinn L, Mazzone T (1994) Clinical evaluation of a semi-permeable polymeric membrane dressing for the treatment of chronic diabetic foot ulcers. Diab Care 17:322-325
6. Bolton LL, Johnson CL, Rijwijk LV (1992) Occlusive dressings: therapeutic agents and effects on drug delivery. Dermatol Clin 9:573-583
7. Calvin M (1998) Cutaneous wound repair. Wounds 10:12-32
8. Cho Ch Y, to JS (1998) Dressing the part. Dermatol Clin 16:25-47
9. Choate ChS (1994) Wound dressings. A comparison of classes and their principles of use. J Am Pod Med Ass 84:463-469
10. Dabi S, Haddock T, Hill AS (1994) Adaptive transparent film dressings. J Biomat Appl 9:14-29
11. Donaghue VM, Chrzan JS, Rosenblum BI, Giurini JM, Habershaw GM, Veves A (1998) Evaluation of a collagen-alginate wound dressing in the management of diabetic foot ulcers. Adv Wound Care 11:114-119
12. Delamaire M, Maugendre D, Moreno M, Le Goff M-C, Allannic H, Genetet B (1997) Impaired leucocyte functions in diabetic patients. Diab Med 14:29-34
13. Eaglestein WH, Falanga V (1997) Tissue engineering and the development of Apligraf, a human skin equivalent. Adv Wound Care [Suppl]:1-8 HTTP://WWW.WOUNDCARENET.COM
14. Flanagan M (1998) The characteristics and formation of granulation tissue. J Wound Care 7:508-510
15. Freak L (1995) Evaluating clinical trials. J Wound Care 4:114-116
16. Gallacher S, Thomson G, Fraser WD, Fisher BM, Gemmell CG, MacCuish AC (1995) Neutrophil bactericidal function in diabetes mellitus: evidence for association with blood glucose control. Diab Med 12:916-950
17. Gawlik ChS (1998) Beurteilung klinischer Therapiestudien. Mindeststandards für den klinischen Alltag. Dtsch Ärztebl 95:A-1155-1160
18. Gentzkow GD, Iwasaki SD, Hershon KS, Mengel M, Prendergast JJ, Ricotta JJ, Steed DP, Lipkin S (1996) Use of dermagraft, a cultured human dermis, to treat diabetic foot ulcers. Diab Care 19:350-354
19. Glover JL, Weingarten MS, Buchbinder DS, Poucher RL, Deitrick GA, Fylling CP (1997) A 4-year-outcome-based retrospective study of wound healing and limb salvage in patients with chronic wounds. Adv Wound Care 10:33-38
20. Goodson WH, Hunt TK (1977) Studies of wound healing in experimental diabetes mellitus. J Surg Res 22:221-227
21. Hanna JR, Giacopelli JA (1997) A review of wound healing and wound dressing products. J Foot Ankle Surg 36:2-14
22. Hehenberger K, Heilborn JD, Brismar K, Hansson A (1998) Inhibited proliferation of fibroblasts derived from chronic diabetic wounds and normal dermal fibroblasts treated with high glucose is associated with increased formation of I-lactate. Wound Repair Regen 6:135-141
23. Hinman CD, Maibach HI (1963) Effect of air exposure and occlusion on experimental human skin wounds. Nature 200:377-378
24. Hutchinson JJ, McGuckin M (1990) Occlusive dressings: a microbiologic and clinical review. Am J Infect Control 18:257-268
25. Kamal K, Du W, Mills I, Sumpio BE (1998) Anti-proliferative effect of elevated glucose in human microvascular endothelial cells. J Cell Biochem 71:491-501
26. Krasner D (1996) Dressing decisions for the twenty-first century: on the cusp of a paradigm shift. Wounds 8:16-23
27. Lawrence JC (1998) A povidone-iodine medicated dressing. J Wound Care 7:332-336
28. Lawrence WTh (1998) Physiology of the acute wound. Clin Plast Surg 25:321-340
29. Ladin DA (1998) Understanding dressings. Clin Plast Surg 25:433-441
30. Lithner F (1990) Adverse effects on diabetic foot ulcers of highly adhesive hydrocolloid occlusive dressings. Diab Care 13:814-815
31. Mayrowitz HN (1997) Shape and area measurement considerations in the assessment of diabetic plantar ulcers. Wounds 9:21-28
32. Mayrovitz HN, Smith J, Ingram C (1998) Comparisons of venous and diabetic plantar ulcer shape and area. Adv Wound Care 11:176-183
33. Nwomeh BC, Yager DR, Cohen IK (1998) Physiology of the chronic wound. Clin Plast Surg 25:341-356
34. Oliveria-Gandia M, Davis St C, Mertzt PM (1998) Can occlusive dressing composition influence proliferation of bacterial wound pathogens? Wounds 10:4-11
35. Ovington LG (1998) The well-dressed wound: an overview of dressing types. Wounds 10 [Suppl A]: 1A-9A
36. Ramasastry SS (1998) Chronic problem wounds. Clin Plast Surg 25:367-396
37. Richard JL, Parer Richard C, Daures JP, Clouet S, Vannereau D, Bringer J, Rodier M, Jacob C, Comte-Bardonnet M (1995) Effect of topical basic fibroblast growth factor on the healing of chronic diabetic neuropathic ulcer of the foot. A pilot, randomized, double-blind, placebo-controlled study. Diab Care 18:64-69
38. Ruckley CV (1997) Evidence-based management of patients with leg ulcers. J Wound Care 6:442-444
39. Schultz GS, Mast BA (1998) Molecular analysis of the environment of healing and chronic wounds: zytokines, proteases, and growth factors. Wounds 10 [Suppl F]: 1F-9F
40. Steed DL, Goslen JB, Holloway GA, Malone JM, Bunt TJ, Webster MW (1992) Randomized prospective double-blind trial in healing chronic diabetic foot ulcers. CT-102 activated platelet supernatant, topical versus placebo. Diab Care 15:1598-604
41. Steed DL, the Diabetic Ulcer Study Group (1995) Clinical evaluation of recombinant human platelet-derived growth factor for the treatment of lower extremity diabetic ulcers. J Vasc Surg 21:71-81
42. Steed DL, Ricotta JJ, Prendergast JJ, Kaplan RJ, Webster MW, McGill JB, Schwartz SL (1995) Promotion and acceleration of diabetic ulcer healing by arginine-glycine-aspartic acid (RGD) peptide matrix. Diab Care 18:39-46
43. Steed DL, Donohoe D, Webster MW, Lindsley L (1996) Effect of extensive debridement and treatment on the healing of diabetic foot ulcers. Diabetic Ulcer Study Group. J Am Coll Surg 183:61-64
44. Thomas DR (1997) Specific nutritional factors in wound healing. Adv Wound Care 10:40-43.
45. N.N. (1998) Update on larval therapy. J Wound Care 7:522-524
46. Vande Berg JS, Ross R, Hollan C, Haywood-reid PL (1998) Fibroblast senescence in pressure ulcers. Wound Rep Reg 6:38-49
47. Winter GD (1962) Formation of the scab and the rate of epithelialization of superficial wound in the skin of young domestic pig. Nature 193:293-294
48. Witkowski JA, Parish LC (1986) Cutaneous ulcer therapy. Int J dermatol 25:420-426
49. Wieman TJ, Smiell JM, Su Y (1998) Efficacy and safety of a topical gel formulation of recominant human platelet-derived growth factor-BB (Becaplemin) in patients with chronic neuropathic diabetic ulcers. Diab Care 21:822-827